share_log

復星醫藥：海外監管公告 - 2023年度股東大會、2024年第一次A股類別股東會及2024年第一次H股類別股東會決議公告

FOSUN PHARMA: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

Hong Kong Stock Exchange ·  Jun 26 19:43
Summary by Futu AI
上海復星醫藥於2024年6月26日召開2023年度股東大會及2024年第一次A股類別股東會和H股類別股東會。會議中，多項議案獲得通過，但修訂《公司章程》及其附件的議案在H股類別股東會上未獲得必要的三分之二以上股份通過，因此該議案被否決。否決該議案不會對集團的日常運營產生影響。會議的召集、召開及表決方式符合相關法律法規和《公司章程》的規定，並由國浩律師（上海）事務所見證。董事會重申，修訂章程的目的是為了與法律法規和上市地監管的最新規定衔接。
上海復星醫藥於2024年6月26日召開2023年度股東大會及2024年第一次A股類別股東會和H股類別股東會。會議中，多項議案獲得通過，但修訂《公司章程》及其附件的議案在H股類別股東會上未獲得必要的三分之二以上股份通過，因此該議案被否決。否決該議案不會對集團的日常運營產生影響。會議的召集、召開及表決方式符合相關法律法規和《公司章程》的規定，並由國浩律師（上海）事務所見證。董事會重申，修訂章程的目的是為了與法律法規和上市地監管的最新規定衔接。
On June 26, 2024, Fosun Pharma in Shanghai held the 2023 Shareholders Meeting, the 2024 First A-Share Class Shareholders Meeting, and the H-Share Class Shareholders Meeting. During the meeting, several proposals were passed, but the proposal to amend the Articles of Association and its attachments did not receive the necessary two-thirds of the shares passed at the H-Share Class Shareholders Meeting and was therefore rejected. The rejection of the proposal will not affect the daily operation of the group. The convocation, holding and voting methods of the meeting comply with relevant laws and regulations and the provisions of the Articles of Association, and have been witnessed by Guohao Law Firm (Shanghai). The Board of Directors reiterated that the purpose of amending the Articles of Association is to align with the latest regulations of laws and regulations and the regulatory requirements of the listing place.
On June 26, 2024, Fosun Pharma in Shanghai held the 2023 Shareholders Meeting, the 2024 First A-Share Class Shareholders Meeting, and the H-Share Class Shareholders Meeting. During the meeting, several proposals were passed, but the proposal to amend the Articles of Association and its attachments did not receive the necessary two-thirds of the shares passed at the H-Share Class Shareholders Meeting and was therefore rejected. The rejection of the proposal will not affect the daily operation of the group. The convocation, holding and voting methods of the meeting comply with relevant laws and regulations and the provisions of the Articles of Association, and have been witnessed by Guohao Law Firm (Shanghai). The Board of Directors reiterated that the purpose of amending the Articles of Association is to align with the latest regulations of laws and regulations and the regulatory requirements of the listing place.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.